Epigenetic mechanisms of liver tumor resistance to immunotherapy

doi:10.4254/wjh.v13.i9.979

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5678)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

340

WORD

HTML

3352

Figures (1-4)

257

Tables (1-1)

263

Sum=4309

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

489

Download

880

Sum=1369

Sep 27, 2021 (publication date) through Nov 29, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hepatol. Sep 27, 2021; 13(9): 979-1002
Published online Sep 27, 2021. doi: 10.4254/wjh.v13.i9.979

Full Size Figure Download Figure

Figure 4 Overview of the main epigenetic mechanisms in hepatocellular carcinoma and their inhibitors. Made with biorender.com. A: DNA methylation; B: Histone modification. DNMT: DNA methyltransferase; TET: Ten-eleven translocation; DNMTis: DNA methyltransferase inhibitors; HAT: Histone acetyl transferase; HDAC: Histone deacetylase; HDACis: Histone deacetylase inhibitors; HMT: Histone methyl transferase; HDM: Histone demethylase; HMTis: Histone methyl transferase inhibitors; HCC: Hepatocellular carcinoma.

Citation: Sanceau J, Gougelet A. Epigenetic mechanisms of liver tumor resistance to immunotherapy. World J Hepatol 2021; 13(9): 979-1002
URL: https://www.wjgnet.com/1948-5182/full/v13/i9/979.htm
DOI: https://dx.doi.org/10.4254/wjh.v13.i9.979